Latest Financial Results News

Energy Action Ltd reported a robust 22.7% increase in revenue to $2.7 million for Q3 FY25, alongside positive operating cash flow and continued investment in its AI-driven Utilibox platform, signaling strong momentum in energy management innovation.

Brazilian Critical Minerals Ltd reports a significant resource upgrade and strong scoping study results for its Ema rare earth project in Brazil, highlighting low operating costs and promising economics.

Universal Biosensors reported a 28% increase in customer receipts to $1.6 million for Q1 2025, alongside improved cash flow and plans for a new product launch later this year.

Locality Planning Energy Holdings Ltd (ASX: LPE) reports a cashflow positive nine months to March 2025, confirms no material impact from Cyclone Alfred, and announces key board appointments to support growth.

Range International reported a 51% revenue increase in Q1 2025 despite supply chain disruptions that dented cash flow. The company is advancing growth initiatives including pallet rentals in Indonesia and expanding production to the Philippines.

N1 Holdings Limited reported a solid FY25 year-to-date profit with revenue growth driven by its SME lending business, while successfully reducing funding costs and maintaining disciplined operations amid ongoing market volatility.

Rand Mining reported a solid March quarter with 4,909 ounces of gold produced and ongoing underground development, though cash reserves dipped to $2.33 million reflecting operational pressures.

American Rare Earths has expanded its Halleck Creek rare earth resource by 12.2% and achieved a metallurgical breakthrough that slashes processing volumes by over 90%, underpinning a robust updated scoping study with strong financial metrics.

Alexium International Group reported a challenging Q3 FY2025 with lower revenues due to softness in the US bedding market, while making significant technological strides and maintaining a solid funding position.

Nova Eye Medical reported a 27% rise in Q3FY25 sales excluding China, driven by record US performance and a sharp reduction in glaucoma segment losses. The company confirmed FY25 revenue guidance and unveiled plans to expand its iTrack™ technology into ocular drug delivery.

Pact Group Holdings reports a modest 2.7% revenue increase for Q3 FY25, driven by higher volumes and cost savings, while preparing to refinance debt and review its Asian packaging business.

QuickFee Limited reported a 29% rise in Q3 FY25 revenue, driven by strong growth in its finance products and Connect platform. However, a significant US credit impairment has prompted a downward revision of its FY25 statutory earnings guidance.